The Society More than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS community Become an ERS member
The PANTHER (Precision medicine Adaptive Network platform Trial in Hypoxemic acutE respiratory failuRe) clinical research collaboration (CRC) was launched by the European Respiratory Society (ERS) in 2023.
The acute respiratory distress syndrome (ARDS) is a heterogeneous clinical syndrome characterised by acute diffuse, inflammatory lung injury resulting in acute hypoxaemic respiratory failure due to noncardiogenic pulmonary oedema. ARDS has a significant global burden and high mortality. No effective pharmacological treatment is currently available, likely due to clinical and biological heterogeneity.
Considerable recent progress has been made towards identifying biological ARDS phenotypes that appear to respond differently to specific interventions in secondary analysis of completed randomised controlled trials. These phenotypes are largely distinguishable by inflammatory biomarkers, suggesting that patients with a specific phenotype may have a more homogeneous inflammatory response. This CRC aims to design an adaptive platform trial which stratifies ARDS patients based on their biological phenotype, enabling a “precision medicine” approach to the pharmacological management of ARDS.
Using near-patient biological testing, these biological phenotypes can now be accurately classified in real-time, facilitating stratified randomisation in a precision medicine trial. As an alternative approach, clinical data may also be used in a machine learning analysis to identify the phenotypes. The proposed trial design will enrol patients with both hyper and hypo-inflammatory ARDS phenotypes, stratifying patients in realtime.
The vision of the PANTHER CRC is to support the development of an international precision medicine platform trial, aiming to efficiently test several pharmacological interventions in hyper-inflammatory and hypo-inflammatory phenotypes in ARDS.
With this purpose, the PANTHER CRC aims specifically to:
The CRC PANTHER is composed of the CRC Chairs, experts in clinical research, early career members, patient representatives and pharma partners.
If you are interested in more information about the CRC PANTHER or would like to join the network, please contact firstname.lastname@example.org.